辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析

doi:10.11904/j.issn.1002-3070.2020.05.001

实用肿瘤学杂志 ›› 2020, Vol. 34 ›› Issue (5): 387-390.doi: 10.11904/j.issn.1002-3070.2020.05.001

• 流行病学研究 • 下一篇

辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析

左婷婷¹, 吴颖², 董首兰³, 曲宁¹, 高岿然¹, 李梦丹¹, 刘运泳¹

1.中国医科大学肿瘤医院;辽宁省肿瘤医院(沈阳 110042);
2.大东区疾病预防控制中心;
3.和平区卫生健康服务与行政执法中心

收稿日期:2020-02-28 出版日期:2020-10-28 发布日期:2020-11-02
通讯作者: 刘运泳,E-mail:liuyunyong@cancerhosp-ln-cmu.com
作者简介:左婷婷,女,(1990-),硕士,医师,从事肿瘤流行病学的研究。
基金资助:
卫健委2012年重大公共卫生服务专项资助

Analysis of breast cancer screening results in urban areas of Shenyang,Liaoning province,2016-2018

ZUO Tingting¹, WU Ying², DONG Shoulan³, QU Ning¹, GAO Kuiran¹, LI Mengdan¹, LIU Yunyong¹

1. Cancer Hospital of China Medical University,Liaoning Cancer Hospital & Institute,Shenyang 110042,China;
2. Dadong District Center for Disease Control and Prevention;
3. Heping District Center for Health Service and Administrative Enforcement

Received:2020-02-28 Online:2020-10-28 Published:2020-11-02

摘要/Abstract

摘要： 目的分析辽宁省沈阳市城市地区乳腺癌筛查效果。方法采用整群抽样的方法,收集2016年11月—2019年3月辽宁沈阳地区40~74岁参与乳腺癌筛查女性的筛查数据,符合要求的女性应用防癌风险评估问卷评估,评估出的高危人群进一步进行临床检查。结果共57664名女性参与乳腺癌高危风险评估,评估出高危人群18885名,5664名女性参与乳腺癌临床检查,阳性(BI-RADS 4-5类)检出率为6.59%,50~59岁年龄段阳性检出率较高,差异有统计学意义(χ²=10.34,P=0.006),不均匀致密型和致密型乳腺中阳性检出率显著高于脂肪型和纤维腺体型(χ²=22.05,P＜0.001)。各年龄段女性乳腺X线技术阳性检出率均高于超声,实质类型中,除外脂肪型,乳腺X线技术阳性检出率均高于超声,差异均有统计学意义(P＜0.05)。结论 50~59岁女性是乳腺癌防控的重点人群,超声在致密型乳腺中阳性病例的检出优势不明显。

关键词: 乳腺癌, 筛查, 城市

Abstract: Objective The aim of this study was to analyze the screening effect of breast cancer in Shenyang,Liaoning province.Methods Cluster sampling method was used to collect the screening data of 40~74 years old women who participated in breast cancer screening in Shenyang area of Liaoning from November 2016 to March 2019.The women who met the requirements were assessed with the cancer prevention risk assessment questionnaire,and the high-risk groups were evaluated for further clinical examination.Results A total of 57664 women participated in the high-risk assessment of breast cancer.Amongst of them,18885 women as the high-risk for breast cancer were assessed,and 5664 women participated in the clinical examination of breast cancer.The positive(BI-RADS 4-5)detection rate was 6.59% in the age group of 50~59 years(χ²=10.34,P=0.006).The positive rate of heterogeneously dense and extremely dense breast type was higher than that of fat type and fibroglandular type(χ²=22.05,P＜0.001).The positive detection rate of mammography in all age groups was higher than that of ultrasound in parenchyma type except for fat type.Conclusion Women aged 50~59 years old are the key population of breast cancer prevention and control,and the detection advantage of ultrasound in the positive cases of dense breast was not obvious.

Key words: Breast cancer, Screening, Urban

中图分类号:

R73-31

左婷婷, 吴颖, 董首兰, 曲宁, 高岿然, 李梦丹, 刘运泳. 辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析[J]. 实用肿瘤学杂志, 2020, 34(5): 387-390.

ZUO Tingting, WU Ying, DONG Shoulan, QU Ning, GAO Kuiran, LI Mengdan, LIU Yunyong. Analysis of breast cancer screening results in urban areas of Shenyang,Liaoning province,2016-2018[J]. Journal of Practical Oncology, 2020, 34(5): 387-390.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.05.001

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I5/387

参考文献

1 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
2 Chen WQ,Zheng RS,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
3 Varghese C,Shin HR.Strengthening cancer control in China[J].Lancet Oncol,2014,15(5):484-485.
4 American College of Radiology.Breast imaging reporting and data system(BI-RADS)[M].5th ed.Reston:Journal of the American College of Radiology.
5 Siegel RL,Miller KD,Jemal A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
6 陈万青,李霓,石菊芳,等.中国城市癌症早诊早治项目进展[J].中国肿瘤,2019,28(1):23-25.
7 孙惠昕,陈王洋,宋冰冰.黑龙江省2013-2014年度城市癌症筛查分析[J].实用肿瘤学杂志,2015,29(4):315-318.
8 肖海帆,颜仕鹏,许可葵,等.湖南省2012-2018年城市癌症早诊早治项目临床筛查结果初步分析[J].中国肿瘤,2019,28(11):807-815.
9 秘子涵,任建松,张洪召,等.2012-2013年中国城市人群乳腺癌筛查结果分析[J].中华预防医学杂志,2016,50(10):887-892.
10 李贺,郑荣寿,张思维,等.2014年中国女性乳腺癌发病与死亡分析[J].中华肿瘤杂志,2018,40(3):166-171.
11 DeSantis CE,Fedewa SA,Goding Sauer A,et al.Breast cancer statistics,2015:Convergence of incidence rates between black and white women[J].CA Cancer J Clin,2016,66(1):31-42.
12 Byrne C,Schairer C,Wolfe J,et al.Mammographic features and breast cancer risk:Effects with time,age,and menopause status[J].J Natl Cancer Inst,1995,87(21):1622-1629.
13 Boyd NF,Lockwood GA,Byng JW,et al.Mammographic densities and breast cancer risk[J].Cancer Epidemiol Biomarkers Prev,1998,7(12):1133-1144.
14 McCormack VA,dosSantos SI.Breast density and parenchymal patterns as markers of breast cancer risk:A meta-analysis[J].Cancer Epidemiol Biomarkers Prev,2006,15(6):1159-1169.
15 Li E,Guida JL,Tian Y,et al.Associations between mammographic density and tumor characteristics in Chinese women with breast cancer[J].Breast Cancer Res Treat,2019,177(2):527-536.
16 Pape R,Spuur K,Umo P.Mammographic parenchymal pattern and breast cancer risk profile of Papua New Guinean women - A baseline study of the screening population[J].Radiography(Lond),2017,23(4):93-98.
17 Stomper PC,D'Souza DJ,DiNitto PA,et al.Analysis of parenchymal density on mammograms in 1353 women 25-79 years old[J].AJR Am J Roentgenol,1996,167(5):1261-1265.
18 Dai H,Yan Y,Wang P,et al.Distribution of mammographic density and its influential factors among Chinese women[J].Int J Epidemiol,2014,43(4):1240-1251.
19 Lauby-Secretan B,Scoccianti C,Loomis D,et al.Breast-cancer screening-viewpoint of the IARC Working Group[J].N Engl J Med,2015,372(24):2353-2358.
20 中国抗癌协会.中国女性乳腺癌筛查指南[J].中国肿瘤临床,2019,46(9):429-431.

[1]	牛明, 于歌. 促进乳腺癌增殖转移和肿瘤干细胞特征的研究[J]. 实用肿瘤学杂志, 2020, 34(6): 518-523.
[2]	刘红, 鲁海玲, 蔡莉. 影像学预测乳腺癌患者预后及新辅助化疗反应的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 535-539.
[3]	肖海帆, 颜仕鹏, 曹世钰, 李娜, 许可葵, 邹艳花, 邓红玉, 杨雯娟, 石朝晖, 廖先珍. 湖南省口腔癌早诊早治项目设计概要[J]. 实用肿瘤学杂志, 2020, 34(6): 544-548.
[4]	袁瑶, 周显礼. 乳腺癌超声特征与腋窝淋巴结转移相关性的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 576-580.
[5]	赵仁成, 林子棠, 余卫军, 雷林, 刘峥, 徐英, 郭艳芳, 彭绩. 2017—2019年深圳市宝安区40~74岁常住居民五癌风险流行状况分析[J]. 实用肿瘤学杂志, 2020, 34(4): 315-320.
[6]	仝潇, 邢佳妮, 王丽虹. 长链非编码RNA HCP5通过调控凋亡通路促进三阴性乳腺癌的研究[J]. 实用肿瘤学杂志, 2020, 34(4): 321-327.
[7]	刘思奇, 边娜娜, 苏亚娟. 超声BI-RADS联合血CA15-3和CEA在乳腺肿物诊断中的价值研究[J]. 实用肿瘤学杂志, 2020, 34(4): 347-351.
[8]	孟瑞瑞, 刘圆圆, 官新立, 周鹏, 许国辉. 低剂量螺旋CT肺癌筛查的研究现状与进展[J]. 实用肿瘤学杂志, 2020, 34(4): 372-376.
[9]	张锐, 李志高. 粘液性乳腺癌的临床研究进展[J]. 实用肿瘤学杂志, 2020, 34(4): 377-381.
[10]	陈都, 钱诚. 乳腺癌肿瘤微环境中间质细胞介导的化疗耐药性研究进展[J]. 实用肿瘤学杂志, 2020, 34(4): 382-386.
[11]	谢贤鑫, 韦军, 邱佳鑫, 王聪, 姜大庆. 乳腺癌新辅助化疗残余肿瘤组织病理信息与预后分析[J]. 实用肿瘤学杂志, 2020, 34(3): 225-231.
[12]	李慧, 庞达. 三阳型乳腺癌的临床病理学特点及辅助治疗[J]. 实用肿瘤学杂志, 2020, 34(3): 262-265.
[13]	赵云霞, 牛波. LncRNA NBAT1通过调控miR-3664-5p/Caspase 9分子轴对人乳腺癌细胞增殖的影响[J]. 实用肿瘤学杂志, 2020, 34(1): 24-29.
[14]	李国政, 庞达. HER2阳性乳腺癌治疗的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 74-78.
[15]	曹涤非, 黄国庆, 薛佳莹, 吴琼, 王雷, 李瑶. CA153在乳腺癌免疫治疗中的作用[J]. 实用肿瘤学杂志, 2019, 33(6): 566-569.

辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析

Analysis of breast cancer screening results in urban areas of Shenyang,Liaoning province,2016-2018

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价